A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 microg twice daily of Formoterol-HFA and 12 microg twice daily of Formoterol-DPI (Foradil/Aerolizer) in children with persistent asthma

Trial Profile

A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 microg twice daily of Formoterol-HFA and 12 microg twice daily of Formoterol-DPI (Foradil/Aerolizer) in children with persistent asthma

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Chiesi Farmaceutici SpA
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top